Elsevier

Biomaterials

Volume 32, Issue 1, January 2011, Pages 65-74
Biomaterials

An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects

https://doi.org/10.1016/j.biomaterials.2010.08.074Get rights and content

Abstract

The treatment of challenging fractures and large osseous defects presents a formidable problem for orthopaedic surgeons. Tissue engineering/regenerative medicine approaches seek to solve this problem by delivering osteogenic signals within scaffolding biomaterials. In this study, we introduce a hybrid growth factor delivery system that consists of an electrospun nanofiber mesh tube for guiding bone regeneration combined with peptide-modified alginate hydrogel injected inside the tube for sustained growth factor release. We tested the ability of this system to deliver recombinant bone morphogenetic protein-2 (rhBMP-2) for the repair of critically-sized segmental bone defects in a rat model. Longitudinal μ-CT analysis and torsional testing provided quantitative assessment of bone regeneration. Our results indicate that the hybrid delivery system resulted in consistent bony bridging of the challenging bone defects. However, in the absence of rhBMP-2, the use of nanofiber mesh tube and alginate did not result in substantial bone formation. Perforations in the nanofiber mesh accelerated the rhBMP-2 mediated bone repair, and resulted in functional restoration of the regenerated bone. μ-CT based angiography indicated that perforations did not significantly affect the revascularization of defects, suggesting that some other interaction with the tissue surrounding the defect such as improved infiltration of osteoprogenitor cells contributed to the observed differences in repair. Overall, our results indicate that the hybrid alginate/nanofiber mesh system is a promising growth factor delivery strategy for the repair of challenging bone injuries.

Introduction

Autologous and allogeneic bone grafting are the most widely used treatment modalities for fracture non-unions and large bone defects [1], [2]. However, these techniques are associated with a number of drawbacks, including the limited graft material available for autografts and the high failure rate of allografts [3], [4], [5]. These limitations have stimulated the search for improved techniques for bone repair, and tissue engineering/regenerative medicine (TE/RM) strategies have demonstrated significant potential in developing bone graft substitutes [6], [7]. These approaches promote tissue repair by providing a combination of physical and biochemical cues through structural scaffolds and biologics [8], [9], [10].

Much of bone TE/RM research is focused on the use of three-dimensional scaffolds having adequate strength to support in vivo loading [11], [12], [13]. However, these structural scaffolds are difficult to design and fabricate at high porosity. They usually do not provide an optimal environment for cellular function and many suffer from slow resorption kinetics, thereby impeding functional restoration of the damaged tissue. We previously demonstrated, for example, that poly(l/dl-lactide) scaffolds infused with recombinant human bone morphogenetic protein-2 (rhBMP-2) promoted bone ingrowth but failed to fully restore the mechanical properties of long bone defects [11]. Thin, two-dimensional membranes have been used to promote bone repair by placing them along the periosteal surface to demarcate the osseous from the non-osseous region [14], [15], [16], [17]. This technique, termed guided bone regeneration, has been applied successfully in the oral and maxillofacial fields to regenerate lost alveolar and skull bone [18], [19], [20]. However, few studies have investigated the use of polymer membranes in the treatment of large defects in load-bearing bones, and none have quantitatively evaluated the restoration of limb function [21], [22], [23].

Electrospun nanofiber meshes have recently emerged as a new generation of scaffold membranes, possessing a number of features suitable for tissue regeneration [24], [25]. They have fibers of the same size-scale of extracellular matrix (ECM) components (fiber diameters ranging from nanometer to sub-micrometer) and a large surface area, which may improve cellular attachment, morphology, migration and function. Nanofiber meshes have been shown to support osteogenic differentiation of progenitor and stem cells in vitro [26], [27], [28], [29], and have been tested in calvarial defect models in vivo [30], [31]. However, their efficacy in guiding long bone regeneration in vivo remains to be investigated.

Though a scaffold provides a template for guiding bone regeneration, biologic factors such as cells, growth factors or genes are typically required to effectively regenerate challenging bone defects [11], [32]. Osteoinductive growth factors like rhBMP-2 have demonstrated some clinical success for bone healing, but large doses are needed [33], [34]. Delivery systems that provide sustained release and improved local retention may provide efficacy at lower protein dose, thereby minimizing complications and making the therapy more cost effective [35], [36], [37], [38]. Alginate hydrogels, made from brown algae derived polysaccharides, have been established as a scaffolding material [39] and a spatiotemporal delivery vehicle for a wide range of proteins [40], [41], [42]. Though mammalian cells lack receptors for alginate polymers, the alginates can be covalently coupled with adhesion peptides to promote cellular attachment [43]. In addition, the degradation rate of these hydrogels can be increased by Gamma-irradiation, resulting in lower molecular weight polymers. These modified alginates have been demonstrated to be better suited for TE/RM applications by allowing faster ingrowth of cells and tissue [39], [44].

The primary objective of this study was to develop and test a hybrid growth factor delivery system for bone repair that utilizes an injectable alginate hydrogel for protein delivery and an electrospun nanofiber mesh for guiding bone regeneration. To test this system, we evaluated its ability to deliver rhBMP-2 for the repair of critically-sized segmental bone defects in vivo. For control group comparisons, we also examined the ability of the nanofiber mesh alone, and in combination with alginate hydrogel, to heal the bone defects without rhBMP-2. Furthermore, the effect of a perforated nanofiber mesh design on bone repair was investigated. We hypothesized that rhBMP-2 delivery in the nanofiber mesh/alginate system would promote bone ingrowth and fully restore the mechanical properties of 8 mm segmental bone defects in the rat model. We further hypothesized that the perforated nanofiber mesh design would accelerate bone ingrowth due to enhanced early defect vascularization. We tested our hypothesis in an in vivo test bed model that utilizes quantitative techniques to assess differences in bone and vascular regrowth and restoration of mechanical function.

Section snippets

Fabrication of nanofiber mesh tubes

Poly(ε-caprolactone) (PCL) pellets (Sigma–Aldrich, St. Louis, MO) were dissolved in a 90:10 volume ratio of hexafluoro-2-propanol (HFP):dimethylformamide (DMF) (Sigma–Aldrich) to obtain a 12% (w/v) polymer solution. DMF was first slowly added to HFP to prevent excessive heat generation, and mixed well on a stir plate for 5 min. The PCL pellets were then added to the solvent solution, and gently stirred for 16–24 h. The solution was visually inspected to ensure a homogeneous and clear solution.

Nanofiber mesh tube characterization and placement

The nanofibers obtained by electrospinning were observed to be smooth and bead-free (Fig. 1A). The fibers ranged in diameter from 51 nm to 974 nm with 82% of the fibers between 50 nm and 150 nm. The mean and the median fiber diameter were calculated to be 154 nm and 107 nm respectively. Despite the high porosity of these meshes (80–90%), the effective pore size was observed to be less than 5 μm. After 5 h of electrospinning, the mesh was found to be approximately 300–400 μm thick. This

Discussion

The treatment of large osseous defects remains a challenge for orthopaedic surgeons. To address this problem, we have developed a growth factor delivery technique for the functional repair of large bone defects using an electrospun nanofiber mesh tube and alginate hydrogel. Tubular scaffolds constructed from nanofiber meshes were placed around segmental defects. Alginate hydrogel containing 5 μg rhBMP-2 was injected into the tubes and constrained within the defect site by the mesh tube. Our

Conclusions

A hybrid growth factor delivery system utilizing an electrospun nanofiber mesh and alginate hydrogel was presented in this study. This system resulted in complete bony bridging of challenging segmental bone defects in a rat model. Perforations accelerated the deposition of mineralized tissue and resulted in functional repair, possibly due to interactions of the surrounding soft tissues with the regenerating bone. The mesh tube alone, or in combination with alginate hydrogel, did not generate a

Acknowledgements

This study was supported with funding from NIH R37 DE013033, NIH R01 AR051336, the Armed Forces Institute for Regenerative Medicine (AFIRM), and the Center for Advanced Engineering and Soldier Survivability (CABSS). The authors would like to thank Dr. Megan Oest for assistance with the segmental defect model and Dr. Craig L. Duvall for advice on μCT-based angiography. We thank Angela Lin and Dr. Laura O’Farrell for assistance with μCT analysis and animal welfare, respectively. We gratefully

References (68)

  • J.L. Drury et al.

    Hydrogels for tissue engineering: scaffold design variables and applications

    Biomaterials

    (2003)
  • E.A. Silva et al.

    Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis

    J Thromb Haemost

    (2007)
  • M.R. Johnson et al.

    Sustained release of BMP-2 in a lipid-based microtube vehicle

    Acta Biomater

    (2009)
  • S. Kokubo et al.

    Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model

    Biomaterials

    (2003)
  • J. Borrelli et al.

    Treatment of nonunions and osseous defects with bone graft and calcium sulfate

    Clin Orthop Relat Res

    (2003)
  • E.D. Arrington et al.

    Complications of iliac crest bone graft harvesting

    Clin Orthop Relat Res

    (1996)
  • B.H. Berrey et al.

    Fractures of allografts. Frequency, treatment, and end-results

    J Bone Jt Surg Am

    (1990)
  • D.L. Wheeler et al.

    Allograft bone decreases in strength in vivo over time

    Clin Orthop Relat Res

    (2005)
  • R.E. Guldberg

    Spatiotemporal delivery strategies for promoting musculoskeletal tissue regeneration

    J Bone Miner Res

    (2009)
  • R.M. Nerem

    Tissue engineering: the hope, the hype, and the future

    Tissue Eng

    (2006)
  • A.J. Salgado et al.

    Bone tissue engineering: state of the art and future trends

    Macromol Biosci

    (2004)
  • R.E. Guldberg et al.

    Biologic augmentation of polymer scaffolds for bone repair

    J Musculoskelet Neuronal Interact

    (2007)
  • M.E. Oest et al.

    Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects

    J Orthop Res

    (2007)
  • B. Rai et al.

    Combination of platelet-rich plasma with polycaprolactone-tricalcium phosphate scaffolds for segmental bone defect repair

    J Biomed Mater Res A

    (2007)
  • R.P. Meinig

    Polylactide membranes in the treatment of segmental diaphyseal defects: animal model experiments in the rabbit radius, sheep tibia, Yucatan minipig radius, and goat tibia

    Injury

    (2002)
  • Z. Gugala et al.

    Healing of critical-size segmental bone defects in the sheep tibiae using bioresorbable polylactide membranes

    Injury

    (2002)
  • U.W. Jung et al.

    Effects of a chitosan membrane coated with polylactic and polyglycolic acid on bone regeneration in a rat calvarial defect

    Biomed Mater

    (2007)
  • R. Mengel et al.

    Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study

    J Periodontol

    (2006)
  • P. Eickholz et al.

    Long-term results of guided tissue regeneration therapy with non-resorbable and bioabsorbable barriers. III. Class II furcations after 10 years

    J Periodontol

    (2006)
  • D. Hutmacher et al.

    A review of material properties of biodegradable and bioresorbable polymers and devices for GTR and GBR applications

    Int J Oral Maxillofac Implants

    (1996)
  • R.P. Meinig et al.

    Bone regeneration with resorbable polymeric membranes: treatment of diaphyseal bone defects in the rabbit radius with poly(l-lactide) membrane. A pilot study

    J Orthop Trauma

    (1996)
  • R. Mosheiff et al.

    Quantification of guided regeneration of weight-bearing bones

    Orthopedics

    (2003)
  • Q.P. Pham et al.

    Electrospinning of polymeric nanofibers for tissue engineering applications: a review

    Tissue Eng

    (2006)
  • R. Murugan et al.

    Nano-featured scaffolds for tissue engineering: a review of spinning methodologies

    Tissue Eng

    (2006)
  • Cited by (0)

    1

    Tel.: +1 404 933 8512; fax: +1 404 385 1397.

    2

    Tel.: +1 404 385 1327; fax: +1 404 385 1397.

    3

    Tel.: +1 617 495 1689.

    4

    Tel.: +1 617 384 9624.

    5

    Tel.: +61 7 3138 6077; fax: +61 7 3138 6030.

    View full text